{"filing":{"accession":"0001106578-26-000125","url":"/filing/0001106578-26-000125","form_type":"4","issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_name_source":null,"issuer_ticker":"UTHR","issuer_url":"/issuer/0001082554","period_of_report":"2026-08-20","filed_date":"2026-08-21","acceptance_dt":"2026-08-21T16:44:01+00:00","acceptance_label":"2026-08-21 16:44 UTC","ingested_at":"2026-08-22T05:23:40.159918+00:00","ingested_label":"2026-08-22 05:23 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000125-index.htm","day_url":"/filings/2026-08-21"},"owners":[{"owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","url":"/insider/0001106578","anchor":"owner-0001106578","role":"Director, Officer (Chairperson & CEO)","officer_title":"Chairperson & CEO","is_director":true,"is_officer":true,"is_ten_percent":false,"is_other":false,"filing_anchor":"/filing/0001106578-26-000125#owner-0001106578"}],"line_owners":[{"owner_name":"ROTHBLATT MARTINE A","role":"Director, Officer (Chairperson & CEO)"}],"transactions":[{"id":9299961,"accession":"0001106578-26-000125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001106578-26-000125","line_url":"/filing/0001106578-26-000125#line-1","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":976.0,"shares_display":"976","price_per_share":518.4483,"price_display":"518.45","price_state":"stated","total_value":506005.5408,"total_display":"506,005.54","total_whole":"506,006","shares_owned_after":332967.0,"shares_owned_after_display":"332,967","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299960,"accession":"0001106578-26-000125","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001106578-26-000125","line_url":"/filing/0001106578-26-000125#line-2","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1504.0,"shares_display":"1,504","price_per_share":519.5107,"price_display":"519.51","price_state":"stated","total_value":781344.0928,"total_display":"781,344.09","total_whole":"781,344","shares_owned_after":331463.0,"shares_owned_after_display":"331,463","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299959,"accession":"0001106578-26-000125","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001106578-26-000125","line_url":"/filing/0001106578-26-000125#line-3","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2357.0,"shares_display":"2,357","price_per_share":520.4551,"price_display":"520.46","price_state":"stated","total_value":1226712.6707,"total_display":"1,226,712.67","total_whole":"1,226,713","shares_owned_after":329106.0,"shares_owned_after_display":"329,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299958,"accession":"0001106578-26-000125","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001106578-26-000125","line_url":"/filing/0001106578-26-000125#line-4","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2470.0,"shares_display":"2,470","price_per_share":521.3939,"price_display":"521.39","price_state":"stated","total_value":1287842.933,"total_display":"1,287,842.93","total_whole":"1,287,843","shares_owned_after":326636.0,"shares_owned_after_display":"326,636","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299957,"accession":"0001106578-26-000125","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001106578-26-000125","line_url":"/filing/0001106578-26-000125#line-5","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":960.0,"shares_display":"960","price_per_share":522.3715,"price_display":"522.37","price_state":"stated","total_value":501476.64,"total_display":"501,476.64","total_whole":"501,477","shares_owned_after":325676.0,"shares_owned_after_display":"325,676","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299956,"accession":"0001106578-26-000125","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001106578-26-000125","line_url":"/filing/0001106578-26-000125#line-6","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":523.2582,"price_display":"523.26","price_state":"stated","total_value":418606.56,"total_display":"418,606.56","total_whole":"418,607","shares_owned_after":324876.0,"shares_owned_after_display":"324,876","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299955,"accession":"0001106578-26-000125","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001106578-26-000125","line_url":"/filing/0001106578-26-000125#line-7","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":240.0,"shares_display":"240","price_per_share":525.0963,"price_display":"525.10","price_state":"stated","total_value":126023.112,"total_display":"126,023.11","total_whole":"126,023","shares_owned_after":324636.0,"shares_owned_after_display":"324,636","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299954,"accession":"0001106578-26-000125","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001106578-26-000125","line_url":"/filing/0001106578-26-000125#line-8","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":193.0,"shares_display":"193","price_per_share":526.9699,"price_display":"526.97","price_state":"stated","total_value":101705.1907,"total_display":"101,705.19","total_whole":"101,705","shares_owned_after":324443.0,"shares_owned_after_display":"324,443","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null}],"n_transactions":8,"line_constants":{"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true},"provenance":{"source_pass":"Layline","parse_status":"parsed","schema_version":null,"retrieved_at":"2026-08-22T05:23:40.159918+00:00","retrieved_label":"2026-08-22 05:23 UTC","primary_document":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000125-index.htm","accepted_at":"2026-08-21T16:44:01+00:00","accepted_label":"2026-08-21 16:44 UTC"},"related":[{"accession":"0001231589-26-000018","url":"/filing/0001231589-26-000018","form_type":"4","issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_name_source":null,"issuer_ticker":"UTHR","issuer_url":"/issuer/0001082554","period_of_report":"2026-08-20","filed_date":"2026-08-21","acceptance_dt":"2026-08-21T16:43:08+00:00","acceptance_label":"2026-08-21 16:43 UTC","ingested_at":"2026-08-22T05:23:40.159918+00:00","ingested_label":"2026-08-22 05:23 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001231589-26-000018-index.htm","day_url":"/filings/2026-08-21"}],"related_rule":"Other filings held for the same issuer and the same period of report. This is a heuristic match, not an authoritative amendment link: the store holds no 4/A-to-original relation and the catalog does not invent one.","canonical_url":"https://ebomi.com/filing/0001106578-26-000125","retrieved_at":"2026-08-27T05:42:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}